Myriad Genetics Inc. (MYGN) climbed in early trade Tuesday, but settled into a range for the majority of the session. The stock finished up by 0.99 at $34.10.
Myriad Genetics climbed to a new high for the year Tuesday, but is now down 0.85 on 92K shares after the bell.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.